Latest Piperazines Stories
OTTAWA, May 6, 2014 /CNW/ - Health Canada today released the April 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue features an article on the risk
First prospective, randomized clinical trial to reflect context of "real world" issues in treating schizophrenia, including recent incarceration and substance abuse TITUSVILLE, N.J.,
MOUNTAIN VIEW, Calif., April 30, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
PURIXAN(TM) (mercaptopurine) Oral Suspension Finally Makes Accurate Dosing Simple for Healthcare Professionals to Achieve--Especially with Children FRANKLIN, Tenn., April 30, 2014 /PRNewswire/
CML-IQ delivers timely, accurate information to help people make informed decisions. Montreal, QC (PRWEB) April 29, 2014 Every day in North America,
TITUSVILLE, N.J., April 22, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., and Janssen Research and Development, LLC, both members of the Johnson & Johnson Family of Companies, announced that
As the FDA published on April 18, consumers are advised not to purchase or use S.W.A.G. because it was found to contain undeclared sildenafil.
On March 31, the FDA issued a clarification on pediatric use of Revatio (sildenafil) explaining that health care professionals must consider whether the benefits of treatment with Revatio are
FAIRFIELD, N.J., March 24, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc.
- Withering but not falling off, as a blossom that persists on a twig after flowering.